STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
19.20
+0.22 (1.16%)
At close: Jul 25, 2025, 4:00 PM
19.20
0.00 (0.00%)
After-hours: Jul 25, 2025, 4:00 PM EDT

Company Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.

It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.

The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.

STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Company
STAAR Surgical Company logo
CountryUnited States
Founded1982
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees1,157
CEOStephen Farrell

Contact Details

Address:
25510 Commercentre Drive
Lake Forest, California 92630
United States
Phone626 303 7902
Websitestaar.com

Stock Details

Ticker SymbolSTAA
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000718937
CUSIP Number852312305
ISIN NumberUS8523123052
Employer ID95-3797439
SIC Code3851

Key Executives

NamePosition
Stephen C. Farrell CFAChief Executive Officer and Director
Warren FoustPresident and Chief Operating Officer
Nathaniel B. Sisitsky Esq.Senior Vice President, Chief Legal Officer, General Counsel and Corporate Secretary
Dr. Magda Michna Ph.D.Chief Development Officer and Chief Clinical, Regulatory and Medical Affairs Officer
Thomas G. FrinziAdvisor
Deborah J. AndrewsChief Financial Officer
Brian MooreVice President of Investor Relations and Corporate Development
Nancy SabinChief Marketing Officer
James FranceseSenior Vice President of Commercial Operations - North America and APAC
Dr. Scott D. Barnes M.D.Chief Medical Officer

Latest SEC Filings

DateTypeTitle
Jun 25, 20258-KCurrent Report
Jun 18, 20258-KCurrent Report
Jun 4, 20258-KCurrent Report
May 16, 20258-KCurrent Report
May 15, 2025SCHEDULE 13GFiling
May 7, 202510-QQuarterly Report
May 7, 20258-KCurrent Report
Apr 30, 2025SCHEDULE 13G/AFiling
Apr 24, 2025ARSFiling
Apr 24, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material